T helper cells in depression: central role of Th17 cells. (2nd January 2022)

• Record Type: Journal Article
• Authors: Ghosh, Raghumoy; Mitra, Prasenjit; Kumar, P. V. S. N. Kiran; Goyal, Taru; Sharma, Praveen
• Is Part Of: Critical reviews in clinical laboratory sciences. Volume 59:Number 1(2022)
• Page Start: 19
• Page End: 39
• Publication Date: 2022-01-02
• Subjects: Depression -- T helper 17 -- interleukin 17 -- neuroinflammation; Diagnosis, laboratory -- Periodicals; Medicine, Clinical -- Periodicals; 616.07
• DOI: 10.1080/10408363.2021.1965535
• Languages: English
• ISSNs: 1040-8363

Abstract

Abstract: Depression is one of the most common neuropsychiatric disorders in the world. While conventional pharmaceutical therapy targets monoaminergic pathway dysfunction, it has not been totally successful in terms of positive outcomes, remission, and preventing relapses. There is an increasing amount of evidence that neuroinflammation may play a significant part in the pathophysiology of depression. Among the key components of the neuroinflammatory pathways already known to be active are the T helper (Th) cells, especially Th17 cells. While various preclinical and clinical studies have reported increased levels of Th17 cells in both serum and brain tissue of laboratory model animals, contradictory results have argued against a pertinent role of Th17 cells in depression. Recent studies have also revealed a role for more pathogenic and inflammatory subsets of Th17 in depression, as well as IL-17A and Th17 cells in non-responsiveness to conventional antidepressant therapy. Despite recent advances, there is still a significant knowledge gap concerning the exact mechanism by which Th17 cells influence neuroinflammation in depression. This review first provides a short introduction to the major findings that led to the discovery of the role of Th cells in depression. The major subsets of Th cells known to be involved in neuroimmunology of depression, such as Th1, Th17, and T regulatory cells, are subsequently described, with an in-depth discussion on current knowledge about Th17 cells in depression.